HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jeremy W Cannon Selected Research

Jeremy W Cannon Research Topics

Disease

36Wounds and Injuries (Trauma)
02/2024 - 08/2012
11Hemorrhage
02/2024 - 07/2011
5Hemorrhagic Shock
02/2024 - 09/2011
5Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
11/2014 - 11/2010
4Hemothorax
01/2024 - 10/2020
4Shock
05/2023 - 09/2011
3Critical Illness (Critically Ill)
02/2024 - 09/2014
3Burns
01/2023 - 03/2015
2Respiratory Insufficiency (Respiratory Failure)
10/2023 - 05/2014
2Pain (Aches)
01/2022 - 01/2022
2Traumatic Brain Injuries (Traumatic Brain Injury)
01/2022 - 09/2021
2Vascular System Injuries
08/2012 - 06/2011
1Gunshot Wounds (Gunshot Wound)
02/2024
1Infections
02/2024
1Contusions
01/2022
1Cough
01/2022
1Compartment Syndromes
08/2021
1Pneumonia (Pneumonitis)
10/2020
1Heart Arrest (Cardiac Arrest)
01/2020
1Hypertension (High Blood Pressure)
05/2018
1Fecal Incontinence
01/2018
1Body Weight (Weight, Body)
01/2018
1Hypercalcemia (Milk Alkali Syndrome)
01/2017
1Hypocalcemia
01/2017
1Acute Necrotizing Pancreatitis
01/2017
1Tachycardia (Tachyarrhythmias)
11/2016
1Hypotension (Low Blood Pressure)
11/2016
1Stevens-Johnson Syndrome (Lyell's Syndrome)
11/2014
1AIDS-Related Complex (ARC)
09/2014
1Diverticulitis
06/2013
1Acidosis
11/2011
1Lung Injury
08/2011
1Patent Ductus Arteriosus
01/2003
1Vascular Ring
01/2003

Drug/Important Bio-Agent (IBA)

3Hemostatics (Antihemorrhagics)IBA
02/2024 - 01/2018
2Explosive Agents (Explosives)IBA
01/2018 - 12/2012
2Crystalloid SolutionsIBA
01/2018 - 08/2013
2Anti-Bacterial Agents (Antibiotics)IBA
09/2014 - 06/2013
1Antifibrinolytic Agents (Antifibrinolytics)IBA
01/2024
1Tranexamic Acid (AMCA)FDA Link
01/2024
1SolutionsIBA
11/2022
1Analgesics (Analgesic Drugs)IBA
01/2022
1KetamineFDA LinkGeneric
01/2022
1Non-Narcotic Analgesics (Analgesics, Non Narcotic)IBA
01/2022
1Adenosine Diphosphate (ADP)IBA
09/2021
1ElementsIBA
08/2021
1Polymethyl Methacrylate (Sol)IBA
01/2021
1Hemoglobins (Hemoglobin)IBA
11/2019
1CalciumIBA
01/2017
1N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA
11/2016
1Matrix Metalloproteinases (MMPs)IBA
10/2015
1CreatinineIBA
09/2014
1PiperacillinFDA LinkGeneric
09/2014
1TazobactamFDA LinkGeneric
09/2014
1Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric
09/2014
1Oleic Acid (Oleate)IBA
03/2014
1Lactic Acid (Lactate)FDA LinkGeneric
11/2011

Therapy/Procedure

20Resuscitation
02/2024 - 07/2011
8Extracorporeal Membrane Oxygenation
10/2023 - 08/2011
7Thoracotomy
02/2024 - 09/2011
7Therapeutics
02/2024 - 11/2010
6Artificial Respiration (Mechanical Ventilation)
11/2016 - 08/2013
5Thoracostomy
01/2024 - 12/2012
5Critical Care (Surgical Intensive Care)
01/2022 - 08/2012
4Blood Transfusion (Blood Transfusions)
01/2023 - 05/2014
3Length of Stay
02/2024 - 10/2020
2Catheters
01/2024 - 01/2017
2Ligation
06/2011 - 01/2003
1Pneumonectomy (Lung Volume Reduction)
10/2023
1Continuity of Patient Care
01/2023
1Craniotomy
03/2022
1Pain Management
01/2022
1Analgesia
01/2022
1Conduction Anesthesia (Regional Anesthesia)
01/2022
1Therapeutic Embolization
01/2022
1Mechanical Ventilators (Ventilator)
01/2022
1Treatment Delay
07/2021
1Anesthesia
01/2021
1Neurosurgical Procedures
05/2018
1Tourniquets
07/2015
1Negative-Pressure Wound Therapy
08/2012